Anti-Cancer Drug Market - Global Outlook and Forecast 2021-2027

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Anti-Cancer Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anti-Cancer Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anti-Cancer Drug Overall Market Size
2.1 Global Anti-Cancer Drug Market Size: 2021 VS 2027
2.2 Global Anti-Cancer Drug Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Anti-Cancer Drug Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Anti-Cancer Drug Players in Global Market
3.2 Top Global Anti-Cancer Drug Companies Ranked by Revenue
3.3 Global Anti-Cancer Drug Revenue by Companies
3.4 Global Anti-Cancer Drug Sales by Companies
3.5 Global Anti-Cancer Drug Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Anti-Cancer Drug Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Anti-Cancer Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Anti-Cancer Drug Players in Global Market
3.8.1 List of Global Tier 1 Anti-Cancer Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Anti-Cancer Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Anti-Cancer Drug Market Size Markets, 2021 & 2027
4.1.2 Avastin
4.1.3 Rituxan
4.1.4 Herceptin
4.1.5 Alimta
4.2 By Type - Global Anti-Cancer Drug Revenue & Forecasts
4.2.1 By Type - Global Anti-Cancer Drug Revenue, 2016-2021
4.2.2 By Type - Global Anti-Cancer Drug Revenue, 2022-2027
4.2.3 By Type - Global Anti-Cancer Drug Revenue Market Share, 2016-2027
4.3 By Type - Global Anti-Cancer Drug Sales & Forecasts
4.3.1 By Type - Global Anti-Cancer Drug Sales, 2016-2021
4.3.2 By Type - Global Anti-Cancer Drug Sales, 2022-2027
4.3.3 By Type - Global Anti-Cancer Drug Sales Market Share, 2016-2027
4.4 By Type - Global Anti-Cancer Drug Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Anti-Cancer Drug Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Home Care
5.2 By Application - Global Anti-Cancer Drug Revenue & Forecasts
5.2.1 By Application - Global Anti-Cancer Drug Revenue, 2016-2021
5.2.2 By Application - Global Anti-Cancer Drug Revenue, 2022-2027
5.2.3 By Application - Global Anti-Cancer Drug Revenue Market Share, 2016-2027
5.3 By Application - Global Anti-Cancer Drug Sales & Forecasts
5.3.1 By Application - Global Anti-Cancer Drug Sales, 2016-2021
5.3.2 By Application - Global Anti-Cancer Drug Sales, 2022-2027
5.3.3 By Application - Global Anti-Cancer Drug Sales Market Share, 2016-2027
5.4 By Application - Global Anti-Cancer Drug Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Anti-Cancer Drug Market Size, 2021 & 2027
6.2 By Region - Global Anti-Cancer Drug Revenue & Forecasts
6.2.1 By Region - Global Anti-Cancer Drug Revenue, 2016-2021
6.2.2 By Region - Global Anti-Cancer Drug Revenue, 2022-2027
6.2.3 By Region - Global Anti-Cancer Drug Revenue Market Share, 2016-2027
6.3 By Region - Global Anti-Cancer Drug Sales & Forecasts
6.3.1 By Region - Global Anti-Cancer Drug Sales, 2016-2021
6.3.2 By Region - Global Anti-Cancer Drug Sales, 2022-2027
6.3.3 By Region - Global Anti-Cancer Drug Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Anti-Cancer Drug Revenue, 2016-2027
6.4.2 By Country - North America Anti-Cancer Drug Sales, 2016-2027
6.4.3 US Anti-Cancer Drug Market Size, 2016-2027
6.4.4 Canada Anti-Cancer Drug Market Size, 2016-2027
6.4.5 Mexico Anti-Cancer Drug Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Anti-Cancer Drug Revenue, 2016-2027
6.5.2 By Country - Europe Anti-Cancer Drug Sales, 2016-2027
6.5.3 Germany Anti-Cancer Drug Market Size, 2016-2027
6.5.4 France Anti-Cancer Drug Market Size, 2016-2027
6.5.5 U.K. Anti-Cancer Drug Market Size, 2016-2027
6.5.6 Italy Anti-Cancer Drug Market Size, 2016-2027
6.5.7 Russia Anti-Cancer Drug Market Size, 2016-2027
6.5.8 Nordic Countries Anti-Cancer Drug Market Size, 2016-2027
6.5.9 Benelux Anti-Cancer Drug Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Anti-Cancer Drug Revenue, 2016-2027
6.6.2 By Region - Asia Anti-Cancer Drug Sales, 2016-2027
6.6.3 China Anti-Cancer Drug Market Size, 2016-2027
6.6.4 Japan Anti-Cancer Drug Market Size, 2016-2027
6.6.5 South Korea Anti-Cancer Drug Market Size, 2016-2027
6.6.6 Southeast Asia Anti-Cancer Drug Market Size, 2016-2027
6.6.7 India Anti-Cancer Drug Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Anti-Cancer Drug Revenue, 2016-2027
6.7.2 By Country - South America Anti-Cancer Drug Sales, 2016-2027
6.7.3 Brazil Anti-Cancer Drug Market Size, 2016-2027
6.7.4 Argentina Anti-Cancer Drug Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Anti-Cancer Drug Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Anti-Cancer Drug Sales, 2016-2027
6.8.3 Turkey Anti-Cancer Drug Market Size, 2016-2027
6.8.4 Israel Anti-Cancer Drug Market Size, 2016-2027
6.8.5 Saudi Arabia Anti-Cancer Drug Market Size, 2016-2027
6.8.6 UAE Anti-Cancer Drug Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Merck
7.1.1 Merck Corporate Summary
7.1.2 Merck Business Overview
7.1.3 Merck Anti-Cancer Drug Major Product Offerings
7.1.4 Merck Anti-Cancer Drug Sales and Revenue in Global (2016-2021)
7.1.5 Merck Key News
7.2 Bristol-Myers Squibb
7.2.1 Bristol-Myers Squibb Corporate Summary
7.2.2 Bristol-Myers Squibb Business Overview
7.2.3 Bristol-Myers Squibb Anti-Cancer Drug Major Product Offerings
7.2.4 Bristol-Myers Squibb Anti-Cancer Drug Sales and Revenue in Global (2016-2021)
7.2.5 Bristol-Myers Squibb Key News
7.3 Bayer
7.3.1 Bayer Corporate Summary
7.3.2 Bayer Business Overview
7.3.3 Bayer Anti-Cancer Drug Major Product Offerings
7.3.4 Bayer Anti-Cancer Drug Sales and Revenue in Global (2016-2021)
7.3.5 Bayer Key News
7.4 GlaxoSmithKline
7.4.1 GlaxoSmithKline Corporate Summary
7.4.2 GlaxoSmithKline Business Overview
7.4.3 GlaxoSmithKline Anti-Cancer Drug Major Product Offerings
7.4.4 GlaxoSmithKline Anti-Cancer Drug Sales and Revenue in Global (2016-2021)
7.4.5 GlaxoSmithKline Key News
7.5 Novartis
7.5.1 Novartis Corporate Summary
7.5.2 Novartis Business Overview
7.5.3 Novartis Anti-Cancer Drug Major Product Offerings
7.5.4 Novartis Anti-Cancer Drug Sales and Revenue in Global (2016-2021)
7.5.5 Novartis Key News
7.6 Sanofi
7.6.1 Sanofi Corporate Summary
7.6.2 Sanofi Business Overview
7.6.3 Sanofi Anti-Cancer Drug Major Product Offerings
7.6.4 Sanofi Anti-Cancer Drug Sales and Revenue in Global (2016-2021)
7.6.5 Sanofi Key News
7.7 Pfizer
7.7.1 Pfizer Corporate Summary
7.7.2 Pfizer Business Overview
7.7.3 Pfizer Anti-Cancer Drug Major Product Offerings
7.4.4 Pfizer Anti-Cancer Drug Sales and Revenue in Global (2016-2021)
7.7.5 Pfizer Key News
7.8 Amgen
7.8.1 Amgen Corporate Summary
7.8.2 Amgen Business Overview
7.8.3 Amgen Anti-Cancer Drug Major Product Offerings
7.8.4 Amgen Anti-Cancer Drug Sales and Revenue in Global (2016-2021)
7.8.5 Amgen Key News
7.9 Celgene Corporation
7.9.1 Celgene Corporation Corporate Summary
7.9.2 Celgene Corporation Business Overview
7.9.3 Celgene Corporation Anti-Cancer Drug Major Product Offerings
7.9.4 Celgene Corporation Anti-Cancer Drug Sales and Revenue in Global (2016-2021)
7.9.5 Celgene Corporation Key News
7.10 Ariad Pharmaceuticals
7.10.1 Ariad Pharmaceuticals Corporate Summary
7.10.2 Ariad Pharmaceuticals Business Overview
7.10.3 Ariad Pharmaceuticals Anti-Cancer Drug Major Product Offerings
7.10.4 Ariad Pharmaceuticals Anti-Cancer Drug Sales and Revenue in Global (2016-2021)
7.10.5 Ariad Pharmaceuticals Key News
7.11 Eli Lilly
7.11.1 Eli Lilly Corporate Summary
7.11.2 Eli Lilly Anti-Cancer Drug Business Overview
7.11.3 Eli Lilly Anti-Cancer Drug Major Product Offerings
7.11.4 Eli Lilly Anti-Cancer Drug Sales and Revenue in Global (2016-2021)
7.11.5 Eli Lilly Key News
7.12 Hoffmann-La Roche Ltd.
7.12.1 Hoffmann-La Roche Ltd. Corporate Summary
7.12.2 Hoffmann-La Roche Ltd. Anti-Cancer Drug Business Overview
7.12.3 Hoffmann-La Roche Ltd. Anti-Cancer Drug Major Product Offerings
7.12.4 Hoffmann-La Roche Ltd. Anti-Cancer Drug Sales and Revenue in Global (2016-2021)
7.12.5 Hoffmann-La Roche Ltd. Key News
7.13 AstraZeneca
7.13.1 AstraZeneca Corporate Summary
7.13.2 AstraZeneca Anti-Cancer Drug Business Overview
7.13.3 AstraZeneca Anti-Cancer Drug Major Product Offerings
7.13.4 AstraZeneca Anti-Cancer Drug Sales and Revenue in Global (2016-2021)
7.13.5 AstraZeneca Key News
7.14 Boehringer Ingelheim GmbH
7.14.1 Boehringer Ingelheim GmbH Corporate Summary
7.14.2 Boehringer Ingelheim GmbH Business Overview
7.14.3 Boehringer Ingelheim GmbH Anti-Cancer Drug Major Product Offerings
7.14.4 Boehringer Ingelheim GmbH Anti-Cancer Drug Sales and Revenue in Global (2016-2021)
7.14.5 Boehringer Ingelheim GmbH Key News
7.15 Teva Pharmaceuticals
7.15.1 Teva Pharmaceuticals Corporate Summary
7.15.2 Teva Pharmaceuticals Business Overview
7.15.3 Teva Pharmaceuticals Anti-Cancer Drug Major Product Offerings
7.15.4 Teva Pharmaceuticals Anti-Cancer Drug Sales and Revenue in Global (2016-2021)
7.15.5 Teva Pharmaceuticals Key News
8 Global Anti-Cancer Drug Production Capacity, Analysis
8.1 Global Anti-Cancer Drug Production Capacity, 2016-2027
8.2 Anti-Cancer Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Anti-Cancer Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Anti-Cancer Drug Supply Chain Analysis
10.1 Anti-Cancer Drug Industry Value Chain
10.2 Anti-Cancer Drug Upstream Market
10.3 Anti-Cancer Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Anti-Cancer Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer


List of Tables
Table 1. Key Players of Anti-Cancer Drug in Global Market
Table 2. Top Anti-Cancer Drug Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Anti-Cancer Drug Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Anti-Cancer Drug Revenue Share by Companies, 2016-2021
Table 5. Global Anti-Cancer Drug Sales by Companies, (K Units), 2016-2021
Table 6. Global Anti-Cancer Drug Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Anti-Cancer Drug Price (2016-2021) & (USD/Unit)
Table 8. Global Manufacturers Anti-Cancer Drug Product Type
Table 9. List of Global Tier 1 Anti-Cancer Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti-Cancer Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Anti-Cancer Drug Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Global Anti-Cancer Drug Revenue (US$, Mn), 2016-2021
Table 13. By Type - Global Anti-Cancer Drug Revenue (US$, Mn), 2022-2027
Table 14. By Type - Global Anti-Cancer Drug Sales (K Units), 2016-2021
Table 15. By Type - Global Anti-Cancer Drug Sales (K Units), 2022-2027
Table 16. By Application - Global Anti-Cancer Drug Revenue, (US$, Mn), 2021 VS 2027
Table 17. By Application - Global Anti-Cancer Drug Revenue (US$, Mn), 2016-2021
Table 18. By Application - Global Anti-Cancer Drug Revenue (US$, Mn), 2022-2027
Table 19. By Application - Global Anti-Cancer Drug Sales (K Units), 2016-2021
Table 20. By Application - Global Anti-Cancer Drug Sales (K Units), 2022-2027
Table 21. By Region - Global Anti-Cancer Drug Revenue, (US$, Mn), 2021 VS 2027
Table 22. By Region - Global Anti-Cancer Drug Revenue (US$, Mn), 2016-2021
Table 23. By Region - Global Anti-Cancer Drug Revenue (US$, Mn), 2022-2027
Table 24. By Region - Global Anti-Cancer Drug Sales (K Units), 2016-2021
Table 25. By Region - Global Anti-Cancer Drug Sales (K Units), 2022-2027
Table 26. By Country - North America Anti-Cancer Drug Revenue, (US$, Mn), 2016-2021
Table 27. By Country - North America Anti-Cancer Drug Revenue, (US$, Mn), 2022-2027
Table 28. By Country - North America Anti-Cancer Drug Sales, (K Units), 2016-2021
Table 29. By Country - North America Anti-Cancer Drug Sales, (K Units), 2022-2027
Table 30. By Country - Europe Anti-Cancer Drug Revenue, (US$, Mn), 2016-2021
Table 31. By Country - Europe Anti-Cancer Drug Revenue, (US$, Mn), 2022-2027
Table 32. By Country - Europe Anti-Cancer Drug Sales, (K Units), 2016-2021
Table 33. By Country - Europe Anti-Cancer Drug Sales, (K Units), 2022-2027
Table 34. By Region - Asia Anti-Cancer Drug Revenue, (US$, Mn), 2016-2021
Table 35. By Region - Asia Anti-Cancer Drug Revenue, (US$, Mn), 2022-2027
Table 36. By Region - Asia Anti-Cancer Drug Sales, (K Units), 2016-2021
Table 37. By Region - Asia Anti-Cancer Drug Sales, (K Units), 2022-2027
Table 38. By Country - South America Anti-Cancer Drug Revenue, (US$, Mn), 2016-2021
Table 39. By Country - South America Anti-Cancer Drug Revenue, (US$, Mn), 2022-2027
Table 40. By Country - South America Anti-Cancer Drug Sales, (K Units), 2016-2021
Table 41. By Country - South America Anti-Cancer Drug Sales, (K Units), 2022-2027
Table 42. By Country - Middle East & Africa Anti-Cancer Drug Revenue, (US$, Mn), 2016-2021
Table 43. By Country - Middle East & Africa Anti-Cancer Drug Revenue, (US$, Mn), 2022-2027
Table 44. By Country - Middle East & Africa Anti-Cancer Drug Sales, (K Units), 2016-2021
Table 45. By Country - Middle East & Africa Anti-Cancer Drug Sales, (K Units), 2022-2027
Table 46. Merck Corporate Summary
Table 47. Merck Anti-Cancer Drug Product Offerings
Table 48. Merck Anti-Cancer Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 49. Bristol-Myers Squibb Corporate Summary
Table 50. Bristol-Myers Squibb Anti-Cancer Drug Product Offerings
Table 51. Bristol-Myers Squibb Anti-Cancer Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 52. Bayer Corporate Summary
Table 53. Bayer Anti-Cancer Drug Product Offerings
Table 54. Bayer Anti-Cancer Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 55. GlaxoSmithKline Corporate Summary
Table 56. GlaxoSmithKline Anti-Cancer Drug Product Offerings
Table 57. GlaxoSmithKline Anti-Cancer Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 58. Novartis Corporate Summary
Table 59. Novartis Anti-Cancer Drug Product Offerings
Table 60. Novartis Anti-Cancer Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 61. Sanofi Corporate Summary
Table 62. Sanofi Anti-Cancer Drug Product Offerings
Table 63. Sanofi Anti-Cancer Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 64. Pfizer Corporate Summary
Table 65. Pfizer Anti-Cancer Drug Product Offerings
Table 66. Pfizer Anti-Cancer Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 67. Amgen Corporate Summary
Table 68. Amgen Anti-Cancer Drug Product Offerings
Table 69. Amgen Anti-Cancer Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 70. Celgene Corporation Corporate Summary
Table 71. Celgene Corporation Anti-Cancer Drug Product Offerings
Table 72. Celgene Corporation Anti-Cancer Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 73. Ariad Pharmaceuticals Corporate Summary
Table 74. Ariad Pharmaceuticals Anti-Cancer Drug Product Offerings
Table 75. Ariad Pharmaceuticals Anti-Cancer Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 76. Eli Lilly Corporate Summary
Table 77. Eli Lilly Anti-Cancer Drug Product Offerings
Table 78. Eli Lilly Anti-Cancer Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 79. Hoffmann-La Roche Ltd. Corporate Summary
Table 80. Hoffmann-La Roche Ltd. Anti-Cancer Drug Product Offerings
Table 81. Hoffmann-La Roche Ltd. Anti-Cancer Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 82. AstraZeneca Corporate Summary
Table 83. AstraZeneca Anti-Cancer Drug Product Offerings
Table 84. AstraZeneca Anti-Cancer Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 85. Boehringer Ingelheim GmbH Corporate Summary
Table 86. Boehringer Ingelheim GmbH Anti-Cancer Drug Product Offerings
Table 87. Boehringer Ingelheim GmbH Anti-Cancer Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 88. Teva Pharmaceuticals Corporate Summary
Table 89. Teva Pharmaceuticals Anti-Cancer Drug Product Offerings
Table 90. Teva Pharmaceuticals Anti-Cancer Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 91. Anti-Cancer Drug Production Capacity (K Units) of Key Manufacturers in Global Market, 2019-2021 (K Units)
Table 92. Global Anti-Cancer Drug Capacity Market Share of Key Manufacturers, 2019-2021
Table 93. Global Anti-Cancer Drug Production by Region, 2016-2021 (K Units)
Table 94. Global Anti-Cancer Drug Production by Region, 2022-2027 (K Units)
Table 95. Anti-Cancer Drug Market Opportunities & Trends in Global Market
Table 96. Anti-Cancer Drug Market Drivers in Global Market
Table 97. Anti-Cancer Drug Market Restraints in Global Market
Table 98. Anti-Cancer Drug Raw Materials
Table 99. Anti-Cancer Drug Raw Materials Suppliers in Global Market
Table 100. Typical Anti-Cancer Drug Downstream
Table 101. Anti-Cancer Drug Downstream Clients in Global Market
Table 102. Anti-Cancer Drug Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Anti-Cancer Drug Segment by Type
Figure 2. Anti-Cancer Drug Segment by Application
Figure 3. Global Anti-Cancer Drug Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Anti-Cancer Drug Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Anti-Cancer Drug Revenue, 2016-2027 (US$, Mn)
Figure 7. Anti-Cancer Drug Sales in Global Market: 2016-2027 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Anti-Cancer Drug Revenue in 2020
Figure 9. By Type - Global Anti-Cancer Drug Sales Market Share, 2016-2027
Figure 10. By Type - Global Anti-Cancer Drug Revenue Market Share, 2016-2027
Figure 11. By Type - Global Anti-Cancer Drug Price (USD/Unit), 2016-2027
Figure 12. By Application - Global Anti-Cancer Drug Sales Market Share, 2016-2027
Figure 13. By Application - Global Anti-Cancer Drug Revenue Market Share, 2016-2027
Figure 14. By Application - Global Anti-Cancer Drug Price (USD/Unit), 2016-2027
Figure 15. By Region - Global Anti-Cancer Drug Sales Market Share, 2016-2027
Figure 16. By Region - Global Anti-Cancer Drug Revenue Market Share, 2016-2027
Figure 17. By Country - North America Anti-Cancer Drug Revenue Market Share, 2016-2027
Figure 18. By Country - North America Anti-Cancer Drug Sales Market Share, 2016-2027
Figure 19. US Anti-Cancer Drug Revenue, (US$, Mn), 2016-2027
Figure 20. Canada Anti-Cancer Drug Revenue, (US$, Mn), 2016-2027
Figure 21. Mexico Anti-Cancer Drug Revenue, (US$, Mn), 2016-2027
Figure 22. By Country - Europe Anti-Cancer Drug Revenue Market Share, 2016-2027
Figure 23. By Country - Europe Anti-Cancer Drug Sales Market Share, 2016-2027
Figure 24. Germany Anti-Cancer Drug Revenue, (US$, Mn), 2016-2027
Figure 25. France Anti-Cancer Drug Revenue, (US$, Mn), 2016-2027
Figure 26. U.K. Anti-Cancer Drug Revenue, (US$, Mn), 2016-2027
Figure 27. Italy Anti-Cancer Drug Revenue, (US$, Mn), 2016-2027
Figure 28. Russia Anti-Cancer Drug Revenue, (US$, Mn), 2016-2027
Figure 29. Nordic Countries Anti-Cancer Drug Revenue, (US$, Mn), 2016-2027
Figure 30. Benelux Anti-Cancer Drug Revenue, (US$, Mn), 2016-2027
Figure 31. By Region - Asia Anti-Cancer Drug Revenue Market Share, 2016-2027
Figure 32. By Region - Asia Anti-Cancer Drug Sales Market Share, 2016-2027
Figure 33. China Anti-Cancer Drug Revenue, (US$, Mn), 2016-2027
Figure 34. Japan Anti-Cancer Drug Revenue, (US$, Mn), 2016-2027
Figure 35. South Korea Anti-Cancer Drug Revenue, (US$, Mn), 2016-2027
Figure 36. Southeast Asia Anti-Cancer Drug Revenue, (US$, Mn), 2016-2027
Figure 37. India Anti-Cancer Drug Revenue, (US$, Mn), 2016-2027
Figure 38. By Country - South America Anti-Cancer Drug Revenue Market Share, 2016-2027
Figure 39. By Country - South America Anti-Cancer Drug Sales Market Share, 2016-2027
Figure 40. Brazil Anti-Cancer Drug Revenue, (US$, Mn), 2016-2027
Figure 41. Argentina Anti-Cancer Drug Revenue, (US$, Mn), 2016-2027
Figure 42. By Country - Middle East & Africa Anti-Cancer Drug Revenue Market Share, 2016-2027
Figure 43. By Country - Middle East & Africa Anti-Cancer Drug Sales Market Share, 2016-2027
Figure 44. Turkey Anti-Cancer Drug Revenue, (US$, Mn), 2016-2027
Figure 45. Israel Anti-Cancer Drug Revenue, (US$, Mn), 2016-2027
Figure 46. Saudi Arabia Anti-Cancer Drug Revenue, (US$, Mn), 2016-2027
Figure 47. UAE Anti-Cancer Drug Revenue, (US$, Mn), 2016-2027
Figure 48. Global Anti-Cancer Drug Production Capacity (K Units), 2016-2027
Figure 49. The Percentage of Production Anti-Cancer Drug by Region, 2020 VS 2027
Figure 50. Anti-Cancer Drug Industry Value Chain
Figure 51. Marketing Channels

Merck
Bristol-Myers Squibb
Bayer
GlaxoSmithKline
Novartis
Sanofi
Pfizer
Amgen
Celgene Corporation
Ariad Pharmaceuticals
Eli Lilly
Hoffmann-La Roche Ltd.
AstraZeneca
Boehringer Ingelheim GmbH
Teva Pharmaceuticals